PM Modi examines oxygen and drug availability amid Covid-19

The oxygen supply is now more than three times what it was during the peak of the first wave of COVID-19, the prime minister’s office said on Wednesday, noting that the production of all drugs, including Remdesivir, has increased dramatically in the past few weeks as India battles the spike in infections nationwide.

At a high-level meeting chaired by Prime Minister Narendra Modi to review the availability and supply of oxygen and drugs, it was noted that states are receiving drugs in good quantity, with the Center in regular contact with manufacturers to improve their production and extend all necessary assistance.

The central government is actively monitoring the supply of drugs used in the management of COVID as well as mucormycosis, a rare fungal infection reported in some locations.

Modi said India has a very vibrant pharmaceutical sector and the government’s close and continuous coordination with them will ensure adequate availability of all medicines.

The PMO said Modi had also been briefed on oxygen rail operations and the exits of IAF planes, in addition to the status of the purchases of oxygen concentrators, oxygen cylinders as well as the state of factories being installed across the country to produce life-saving gas.

Amid reports of unused fans in some states, with local authorities blaming quality issues in a few cases, Modi said states should be urged to operationalize them within a specified time frame and resolve technical and training issues. with the help of manufacturers.

Dear reader,

Business Standard has always strived to provide up-to-date information and commentary on developments that matter to you and have broader political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering has only strengthened our resolve and commitment to these ideals. Even in these difficult times resulting from Covid-19, we remain committed to keeping you informed and updated with credible news, authoritative views and cutting edge commentary on relevant current issues.
However, we have a demand.

As we fight the economic impact of the pandemic, we need your support even more so that we can continue to provide you with more quality content. Our subscription model has received an encouraging response from many of you who have subscribed to our online content. More subscriptions to our online content can only help us achieve the goals of providing you with even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital editor

Source link

Comments are closed.